Sensitive and specific detection of breast cancer lymph node metastasis through dual-modality magnetic particle imaging and fluorescence molecular imaging: a preclinical evaluation
Open Access
- 20 May 2022
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 49 (8) , 2723-2734
Abstract
Purpose: A sensitive and specific imaging method to detect metastatic cancer cells in lymph nodes to detect the early-stage breast cancer is still a challenge. The purpose of this study was to investigate a novel breast cancer–targeting and tumour microenvironment ATP-responsive superparamagnetic iron oxide nanoparticles (SPIOs) imaging probe (abbreviated as SPIOs@A-T) that was developed to detect lymph node metastasis through fluorescence molecular imaging (FMI) and magnetic particle imaging (MPI). Methods: The conjugation of the targeted peptide CREKA and SPIOs was via linker sulfo-SMCC, while the dsDNA-Cy5.5 was modified on SPIOs through the conjugation between maleimide group in sulfo-SMCC and sulfydryl group in dsDNA-Cy5.5. SPIOs@A-T was characterised for its imaging properties, targeting ability and toxicity in vitro. Mice with metastatic lymph node (MLN) of breast cancer were established to evaluate the FMI and MPI imaging strategy in vivo. Healthy mice with normal lymph node (NLN) were used as control group. Histological examination and biosafety evaluation were performed for further assessment. Results: After injection with SPIOs@A-T, the obvious high fluorescent intensity and MPI signal were observed in MLN group than those in NLN group. FMI can specifically light up MLN using an ATP-responsive fluorescence design. On the other hand, MPI could complement the limitation of imaging depth from FMI and could detect MLN more sensitively. Besides, the biosafety evaluation results showed SPIOs@A-T had no detectable biological toxicity. Conclusion: SPIOs@A-T imaging probe in combination with FMI and MPI can provide a promising novel method for the precise detection of MLN in vivo.Keywords
All Related Versions
Funding Information
- Beijing Natural Science Foundation (7212207)
- National Natural Science Foundation of China (81871422, 62027901, 81871514, 81227901, 81470083, 81527805)
- Ministry of Science and Technology of China (2017YFC1309100, 2017YFC1309104, 2017YFA0205200, 2017YFA0700401)
This publication has 34 references indexed in Scilit:
- Optimization and Design of Magnetic Ferrite Nanoparticles with Uniform Tumor Distribution for Highly Sensitive MRI/MPI Performance and Improved Magnetic Hyperthermia TherapyNano Letters, 2019
- Human-sized magnetic particle imaging for brain applicationsNature Communications, 2019
- Serum miRNA–based Prediction of Axillary Lymph Node Metastasis in Breast CancerClinical Cancer Research, 2019
- Enhancing Antitumor Efficacy by Simultaneous ATP‐Responsive Chemodrug Release and Cancer Cell Sensitization Based on a Smart NanoagentAdvanced Science, 2018
- Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancerNature Communications, 2018
- Extracellular ATP and P2 purinergic signalling in the tumour microenvironmentNature Reviews Cancer, 2018
- Upconversion Luminescence-Activated DNA Nanodevice for ATP Sensing in Living CellsJournal of the American Chemical Society, 2018
- Role of ICG-99mTc-nanocolloid for sentinel lymph node detection in cervical cancer: a pilot studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- ATP-Responsive and Near-Infrared-Emissive Nanocarriers for Anticancer Drug Delivery and Real-Time ImagingTheranostics, 2016
- Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United StatesJAMA, 2015